Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Philip Morris International Inc.PM · Entity 2818 | Pres. Smoke-Free Oral Products | March 06, 2025 | March 07, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Philip Morris International Inc.
Report date March 06, 2025 · Filed March 07, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 26,828 |
Reported balance
After 2025-03-06 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-03-06 · Sale · Disposed 3,679 · Balance 26,828 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.96 to $152.98, inclusive. The reporting person undertakes to provide to Philip Morris International Inc., any security holder of Philip Morris International Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. F2: Includes 20,930 Restricted Share Units. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.96 to $152.98, inclusive. The reporting person undertakes to provide to Philip Morris International Inc., any security holder of Philip Morris International Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
F2: Includes 20,930 Restricted Share Units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 06, 2025 Filed Mar 7, 2025 18:51 UTC | Philip Morris International Inc. PM · Entity 2818 | SaleCommon Stock | 3,679 | $152.96 | $562,739.84 |
DisclosureSEC source: 0001413329-25-000083 · wk-form4_1741373457.xml · nonDerivative · entry 1 Dahlgren Lars · CIK 0001960646 · Pres. Smoke-Free Oral Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,828 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.96 to $152.98, inclusive. The reporting person undertakes to provide to Philip Morris International Inc., any security holder of Philip Morris International Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. F2 · balance_after: Includes 20,930 Restricted Share Units. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 17:01 UTC | Philip Morris International Inc. PM · Entity 2818 | Tax withholdingCommon Stock | 6,925 | $149.80 | $1,037,365.00 |
DisclosureSEC source: 0001413329-25-000069 · wk-form4_1740157289.xml · nonDerivative · entry 1 Dahlgren Lars · CIK 0001960646 · Pres. Smoke-Free Oral Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,507 F1 · shares: Withholding of shares of Philip Morris International Inc. common stock to satisfy tax obligations in connection with the vesting of Restricted Share Units and Performance Stock Units. F2 · balance_after: Includes 20,930 Restricted Share Units. Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 21:21 UTC | Philip Morris International Inc. PM · Entity 2818 | GrantCommon Stock | 8,653 | $0.00 | $0.00 |
DisclosureSEC source: 0001413329-25-000034 · wk-form4_1738963261.xml · nonDerivative · entry 1 Dahlgren Lars · CIK 0001960646 · Pres. Smoke-Free Oral Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,432 F1 · shares: Reflects shares of common stock earned as a result of the certification by the Issuer's Board of Directors to the achievement of the year three performance goal under the terms of Performance Stock Units ("PSUs") awarded on December 8, 2022. The PSUs vest on February 19, 2025. F2 · balance_after: Includes 25,100 Restricted Share Units. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 20:26 UTC | Philip Morris International Inc. PM · Entity 2818 | Tax withholdingCommon Stock | 4,881 | $90.57 | $442,072.17 |
DisclosureSEC source: 0001413329-24-000054 · wk-form4_1708719952.xml · nonDerivative · entry 1 Dahlgren Lars · CIK 0001960646 · Pres. Smoke-Free Oral Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,779 F1 · shares: Withholding of shares of Philip Morris International Inc. common stock to satisfy tax obligations in connection with the vesting of Restricted Share Units and Performance Stock Units. F2 · price: Represents the average closing price of the common stock of Philip Morris International Inc. on February 21, 2024. F3 · balance_after: Includes 25,100 Restricted Share Units. Read SEC document |
| February 08, 2024 Filed Feb 9, 2024 23:29 UTC | Philip Morris International Inc. PM · Entity 2818 | GrantCommon Stock | 5,220 | $92.56 | $483,142.32 |
DisclosureSEC source: 0001413329-24-000035 · wk-form4_1707521373.xml · nonDerivative · entry 2 Dahlgren Lars · CIK 0001960646 · Pres. Smoke-Free Oral Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,660 F2 · shares: Restricted Share Units awarded under the Philip Morris International Inc. 2022 Performance Incentive Plan. These Restricted Share Units will vest on February 17, 2027. F3 · price: Represents the average closing price of the common stock of Philip Morris International Inc. for 20 trading days prior to February 8, 2024. F4 · balance_after: Includes 27,880 Restricted Share Units. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 23:29 UTC | Philip Morris International Inc. PM · Entity 2818 | GrantCommon Stock | 5,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001413329-24-000035 · wk-form4_1707521373.xml · nonDerivative · entry 1 Dahlgren Lars · CIK 0001960646 · Pres. Smoke-Free Oral Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,440 F1 · shares: Reflects 5,780 shares of common stock earned as a result of the certification by the Issuer's Board of Directors to the achievement of the three-year performance goals under the terms of Performance Stock Units ("PSUs") awarded on December 8, 2022. The PSUs vest on February 21, 2024. Read SEC document |
| February 09, 2023 Filed Feb 11, 2023 00:10 UTC | Philip Morris International Inc. PM · Entity 2818 | GrantCommon Stock | 4,150 | $102.38 | $424,860.40 |
DisclosureSEC source: 0001413329-23-000053 · wf-form4_167607419843569.xml · nonDerivative · entry 1 Dahlgren Lars · CIK 0001960646 · Pres. Smoke-Free Oral Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,660 F1 · shares: Restricted Share Units awarded under the Philip Morris International Inc. 2022 Performance Incentive Plan. These Restricted Share Units will vest on February 18, 2026. F2 · price: Represents the average closing price of the common stock of Philip Morris International Inc. for 20 trading days prior to February 9, 2023. F3 · balance_after: Represents Restricted Share Units, 2,780 of which vest on February 21, 2024, 4,170 of which vest on February 19, 2025, and 15,710 of which vest on February 18, 2026. Each Restricted Share Unit represents a contingent right to receive one share of common stock of Philip Morris International Inc. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.